|
Volumn 56, Issue 5, 1999, Pages 335-341
|
Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions;Ocena skuteczności i bezpieczeństwa stosowania akarbozy w leczeniu cukrzycy. Badanie obserwacyjne w warunkach podstawowej opieki zdrowotnej.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACARBOSE;
ALPHA GLUCOSIDASE;
ANTIDIABETIC AGENT;
BIGUANIDE DERIVATIVE;
CHOLESTEROL;
SULFONYLUREA DERIVATIVE;
TRIACYLGLYCEROL;
ADULT;
AGED;
ARTICLE;
BLOOD;
BODY MASS;
CARBOHYDRATE METABOLISM;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
ENZYMOLOGY;
FEMALE;
HUMAN;
INTESTINE;
MALE;
METABOLISM;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT COMPLIANCE;
PATIENT SATISFACTION;
POLAND;
WEIGHT REDUCTION;
ACARBOSE;
ADULT;
AGED;
AGED, 80 AND OVER;
ALPHA-GLUCOSIDASES;
BIGUANIDES;
BODY MASS INDEX;
CARBOHYDRATE METABOLISM;
CHOLESTEROL;
DIABETES MELLITUS, TYPE 2;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INTESTINES;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PATIENT SATISFACTION;
POLAND;
SULFONYLUREA COMPOUNDS;
TRIGLYCERIDES;
WEIGHT LOSS;
|
EID: 0032606845
PISSN: 00332240
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|